These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8794825)

  • 21. Src family kinases and nitric oxide production are required for hepatocyte growth factor-stimulated endothelial cell growth.
    Maejima Y; Ueba H; Kuroki M; Yasu T; Hashimoto S; Nabata A; Kobayashi N; Ikeda N; Saito M; Kawakami M
    Atherosclerosis; 2003 Mar; 167(1):89-95. PubMed ID: 12618272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.
    Jiang WG; Hiscox SE; Parr C; Martin TA; Matsumoto K; Nakamura T; Mansel RE
    Clin Cancer Res; 1999 Nov; 5(11):3695-703. PubMed ID: 10589789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
    Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
    Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells.
    Kuba K; Matsumoto K; Ohnishi K; Shiratsuchi T; Tanaka M; Nakamura T
    Biochem Biophys Res Commun; 2000 Dec; 279(3):846-52. PubMed ID: 11162438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive rats.
    Matsumoto K; Morishita R; Tomita N; Moriguchi A; Komai N; Aoki M; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Heart Vessels; 2003 Mar; 18(1):18-25. PubMed ID: 12644877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells.
    Yo Y; Morishita R; Nakamura S; Tomita N; Yamamoto K; Moriguchi A; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Kidney Int; 1998 Oct; 54(4):1128-38. PubMed ID: 9767528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum hepatocyte growth factor is associated with viral hepatitis, cardiovascular disease, erythropoietin treatment, and type of heparin in haemodialysis patients.
    Borawski J; Myśliwiec M
    Nephrol Dial Transplant; 2002 Apr; 17(4):637-44. PubMed ID: 11917058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis.
    Van Belle E; Witzenbichler B; Chen D; Silver M; Chang L; Schwall R; Isner JM
    Circulation; 1998 Feb; 97(4):381-90. PubMed ID: 9468212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of nifedipine on endothelial function in normotensive smokers: potential contribution of increase in circulating hepatocyte growth factor.
    Yamasaki K; Aoki M; Makino H; Hashiya N; Shimizu H; Ohishi M; Ogihara T; Morishita R
    J Hum Hypertens; 2004 Oct; 18(10):701-5. PubMed ID: 15071489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells.
    Hayashi S; Morishita R; Higaki J; Aoki M; Moriguchi A; Kida I; Yoshiki S; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Biochem Biophys Res Commun; 1996 Mar; 220(3):539-45. PubMed ID: 8607801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of Bcl-2, but not Bcl-xL and Bax, to antiapoptotic actions of hepatocyte growth factor in hypoxia-conditioned human endothelial cells.
    Yamamoto K; Morishita R; Hayashi S; Matsushita H; Nakagami H; Moriguchi A; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Hypertension; 2001 May; 37(5):1341-8. PubMed ID: 11358951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel role for endogenous hepatocyte growth factor in the pathogenesis of intracranial aneurysms.
    Peña-Silva RA; Chalouhi N; Wegman-Points L; Ali M; Mitchell I; Pierce GL; Chu Y; Ballas ZK; Heistad D; Hasan D
    Hypertension; 2015 Mar; 65(3):587-93. PubMed ID: 25510828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats.
    Matsumoto K; Morishita R; Moriguchi A; Tomita N; Yo Y; Nishii T; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1999 Aug; 34(2):279-84. PubMed ID: 10454454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum hepatocyte growth factor concentration in obese women decreases after vertical banded gastroplasty.
    Swierczynski J; Korczynska J; Goyke E; Adrych K; Raczynska S; Sledzinski Z
    Obes Surg; 2005; 15(6):803-8. PubMed ID: 15978151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of coronary artery disease on expression and microvascular response to VEGF.
    Métais C; Li J; Li J; Simons M; Sellke FW
    Am J Physiol; 1998 Oct; 275(4):H1411-8. PubMed ID: 9746492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and environmental determinants of hepatocyte growth factor levels and their association with obesity and blood pressure.
    Vistoropsky Y; Trofimov S; Malkin I; Kobyliansky E; Livshits G
    Ann Hum Biol; 2008; 35(1):93-103. PubMed ID: 18274928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of Intracavernous Delivery of Recombinant Human Hepatocyte Growth Factor on Erectile Function in the Streptozotocin-Induced Diabetic Mouse.
    Das ND; Yin GN; Choi MJ; Song KM; Park JM; Limanjaya A; Ghatak K; Minh NN; Ock J; Park SH; Kim HM; Ryu JK; Suh JK
    J Sex Med; 2016 Nov; 13(11):1618-1628. PubMed ID: 27770854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte growth factor prevents endothelial cell death through inhibition of bax translocation from cytosol to mitochondrial membrane.
    Nakagami H; Morishita R; Yamamoto K; Taniyama Y; Aoki M; Yamasaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Diabetes; 2002 Aug; 51(8):2604-11. PubMed ID: 12145177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro.
    Sato Y; Okamura K; Morimoto A; Hamanaka R; Hamaguchi K; Shimada T; Ono M; Kohno K; Sakata T; Kuwano M
    Exp Cell Res; 1993 Feb; 204(2):223-9. PubMed ID: 7679996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kringle 1 of human hepatocyte growth factor inhibits bovine aortic endothelial cell proliferation stimulated by basic fibroblast growth factor and causes cell apoptosis.
    Xin L; Xu R; Zhang Q; Li TP; Gan RB
    Biochem Biophys Res Commun; 2000 Oct; 277(1):186-90. PubMed ID: 11027661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.